Mili Mandal

Mili Mandal currently serves as the Director of Clinical Biomarker Sciences in Clinical Development at IDEAYA Biosciences, a position held since June 2023. Previous roles include Associate Director of Translational Science at Artiva Biotherapeutics and Senior Scientist/Group Leader in CAR-T Cancer Immunotherapy at Fate Therapeutics Inc. Additionally, Mili Mandal held a position as Associate Director for the International Immuno-oncology Network Research Liaison at Bristol-Myers Squibb and served as an Investigator in Translational Sciences at GSK. Mili Mandal's early career involved post-doctoral research at Rutgers University and a Medical Cytogenetic Technologist role at West Virginia University Hospital, complemented by graduate research assistant work. Educational achievements include a Ph.D. in Molecular Pathology and Immunology from Rutgers University and two master's degrees in Plant and Soil Sciences and Plant Sciences, respectively.